Gracias a estaPostgraduate diploma 100% online, llevarás a cabo campañas de promoción de la salud y educación sanitaria dirigidas a diferentes públicos” 

La Vigilancia de la Salud Pública es un aspecto fundamental para identificar y controlar enfermedades infecciosas y crónicas a nivel global. A este respecto, un reciente informe de la Organización Mundial de la Salud desvela que durante los últimos años han fallecido aproximadamente 1.5 millones de personas debido a la Tuberculosis. Esto subraya la importancia de llevar a cabo una vigilancia eficaz para su control. En este sentido, los enfermeros desempeñan un papel clave en la recopilación y análisis de datos epidemiológicos. Por eso, deben interpretar estas informaciones con precisión para comprender la dinámica de las enfermedades y planificar cuidados efectivos.  

En este escenario, TECH implementa un pionero programa en Public Health Surveillance for Nursing. El itinerario académico profundizará en el manejo de los Sistemas de Autocontrol más innovadores, ateniendo a factores como los puntos de control críticos. el establecimiento de protocolos preventivos o la evaluación de riesgos. Asimismo, el temario ahondará en los procedimientos que los enfermeros deben seguir ante alertas, brotes epidémicos y emergencias. También los materiales didácticos analizarán una variedad de técnicas para prevenir tanto enfermedades transmisibles como ni transmisibles, haciendo hincapié en el Cáncer. De este modo, los egresados desarrollarán competencias avanzadas para monitorear el estado de los individuos y planificar programas para promover una óptima Salud Pública. 

Por otro lado, la titulación universitaria se imparte de forma completamente online para que los enfermeros puedan personalizar su tiempo de estudio. Además, TECH emplea su innovador sistema de aprendizaje: el Relearning. Este permite que los profesionales afiancen los conceptos del temario de forma progresiva y natural, sin la necesidad de recurrir a técnicas costosas como la tradicional memorización. Para acceder al Campus Virtual, lo único que necesitarán es un dispositivo electrónico con conexión a internet. De este modo, los egresados podrán disfrutar los recursos educativos más dinámicos del mercado y experimentar un notable salto de calidad en sus trayectorias laborales.    

Esta titulación universitaria te equipará con los recursos necesarios para superar los retos futuros en Vigilancia de la Salud Pública”

Esta Postgraduate diploma en Public Health Surveillance for Nursing contiene el programa científico más completo y actualizado del mercado. Sus características más destacadas son:

• El desarrollo de casos prácticos presentados por expertos Salud Pública y Gestión de la Salud 
• Los contenidos gráficos, esquemáticos y eminentemente prácticos con los que está concebido recogen una información científica y práctica sobre aquellas disciplinas indispensables para el ejercicio profesional 
• Los ejercicios prácticos donde realizar el proceso de autoevaluación para mejorar el aprendizaje 
• Su especial hincapié en metodologías innovadoras 
• Las lecciones teóricas, preguntas al experto, foros de discusión de temas controvertidos y trabajos de reflexión individual 
• La disponibilidad de acceso a los contenidos desde cualquier dispositivo fijo o portátil con conexión a internet

Profundizarás en los últimos avances en Sistemas de Control de Farmacovigilancia y serás capaz de identificar señales de posibles riesgos asociados con los medicamentos”  

El programa incluye en su cuadro docente a profesionales del sector que vierten en esta capacitación la experiencia de su trabajo, además de reconocidos especialistas de sociedades de referencia y universidades de prestigio.  

Su contenido multimedia, elaborado con la última tecnología educativa, permitirá al profesional un aprendizaje situado y contextual, es decir, un entorno simulado que proporcionará una capacitación inmersiva programada para entrenarse ante situaciones reales.  

El diseño de este programa se centra en el Aprendizaje Basado en Problemas, mediante el cual el profesional deberá tratar de resolver las distintas situaciones de práctica profesional que se le planteen a lo largo del curso académico. Para ello, contará con la ayuda de un novedoso sistema de vídeo interactivo realizado por reconocidos expertos.

Adquirirás un enfoque integral orientado a la prevención de enfermedades crónicas, lo que te permitirá fomentar un envejecimiento saludable y sostenible"

Reforzarás tus conocimientos mediante la innovadora metodología Relearning de TECH, que te asegurará una asimilación efectiva de la materia"

Through this university program, nurses will perform health surveillance activities and contribute to the improvement of community health.  

The syllabus will analyze in detail the mechanisms for the design of health protection programs, as well as the interpretation of epidemiological data on chronic diseases.  Likewise, the syllabus will delve into the risk factors of cancer, enabling graduates to detect risk factors and apply prevention strategies. The didactic contents will also provide the most innovative tools to evaluate the quality of intervention studies.   

A high level syllabus that covers the latest scientific postulates in Clinical Epidemiology”

Module 1. Public Health Surveillance 

1.1. Protection, Prevention and Surveillance in Public Health: Classification, Evaluation, Management and Risk Control and Communication 

1.1.1. Health Protection and Prevention 
1.1.2. Health Surveillance and Risk Management 
1.1.3. Risk Communication Mechanisms and Limitations 

1.2. Self-control and Surveillance Systems: Hazard Analysis and Critical Control Points 

1.2.1. Establishment of Preventive Protocols 
1.2.2. Identification and Risk Assessment 
1.2.3. Implementation and Follow-up Control Points 

1.3. Research and Critical Analysis of Process and Outcome Indicators, Records, and Evaluation Systems Development and Innovation 

1.3.1. Research and Analysis of Indicators 
1.3.2. Recording and Evaluation for Efficient Data Management 
1.3.3. Innovation in Evaluation Systems 

1.4. Research in the Design, Implementation, and Impact Evaluation of Health Protection and Prevention Programs 

1.4.1. Mechanisms for the Design of Health Protection and Prevention Programs 
1.4.2. Implementation of Health Protection and Prevention Programs 
1.4.3. Analysis of the Impact of Health Protection and Prevention Programs 

1.5. Analysis and Interpretation of Epidemiological Data on Environmental Health: Surveillance, Estimation, Plans and Programs 

1.5.1. Importance of Environmental Health in Human Health. 
1.5.2. Exploration of Environmental Epidemiological Data 
1.5.3. Practical Application of Environmental Data Analysis 

1.6. Interpretation of Epidemiological Data on Chronic Diseases and Planning: Surveillance, Estimation, Design of Plans, Programs, and Screening 

1.6.1. Epidemiological Analysis of Chronic Diseases Importance of Monitoring 
1.6.2. Design and Development of Interventions for Chronic Diseases 
1.6.3. Epidemiological Surveillance and Disease Burden Analysis 

1.7. Research in Primary Prevention of Chronic Diseases: Health Protection 

1.7.1. Research in Primary Prevention of Chronic Diseases 
1.7.2. Applied Research in Health Prevention and Protection 
1.7.3. Impact Evaluation and Communication of Results 

1.8. Innovation in Pharmacovigilance Monitoring and Prevention Systems: Alerts and Preventive Interventions 

1.8.1. Importance of Pharmacovigilance Safety in the Use of Drugs 
1.8.2. Advances in Pharmacovigilance Monitoring Systems. 
1.8.3. Risk Prevention Through Preventive Interventions 

1.9. Models of Response to Alerts, Epidemic Outbreaks and Emergencies Development of Protocols and Procedures 

1.9.1. Response Strategies for Health Emergencies 
1.9.2. Development of Crisis Management Protocols 
1.9.3. Implementation and Evaluation of Emergency Response 

1.10. International Health and Innovation in International Cooperation for Epidemiological Surveillance 

1.10.1. International Health Global Perspective on Epidemiological Surveillance 
1.10.2. Innovation in International Cooperation for Epidemiological Surveillance 
1.10.3. Challenges and Future of International Cooperation in Health 

Module 2. Epidemiology and Prevention of Communicable and Non-communicable Diseases 

2.1. Epidemiology of Cancer:  Risk Factors and Primary Prevention  

2.1.1. Descriptive Epidemiology: Incidence, Mortality and Data Sources 
2.1.2. Cancer Risk Factors: Environmental and Occupational  
2.1.3. Other Factors: Ultraviolet Light, Infections, Radiation 

2.2. Risk Factors and Primary Prevention of Cancer: Lifestyle and Screening  

2.2.1. Primary Prevention Risk Factors and Prevention Strategies 
2.2.2. Legislative Measures  
2.2.3. Secondary Prevention  

2.3. Biological Mechanisms of Cardiovascular Disease  Estimation of Cardiovascular Risk and Population Prevention 

2.3.1. Ischemic Heart Disease and Stroke 
2.3.2. Epidemiological Indicators  
2.3.3. Classification of Cardiovascular Risk  
2.3.4. Prevention and Control of Cardiovascular Diseases 

2.4. Detection of Rare Diseases and Neonatal Screening 

2.4.1. Rare Diseases 
2.4.2. Newborn Screening Programs 
2.4.3. Neonatal Screening for Congenital Metabolic and Endocrinologic Diseases 

2.5. Comprehensive Approach to Chronic Disease Prevention for Healthy and Sustainable Aging 

2.5.1. Healthy Aging 
2.5.2. Active Aging 
2.5.3. Integrated Prevention 

2.6. Epidemiology of Communicable Diseases: Epidemiologic Surveillance Systems and Notifiable Disease Systems 

2.6.1. Causative Agents  
2.6.2. Time Periods  
2.6.3. Transmission  
2.6.4. Host and Susceptible Population  
2.6.5. Epidemiological Surveillance Systems 

2.7. Utility of Vaccines in the Prevention of Immunopreventable Infectious Diseases 

2.7.1. Analysis of the Importance of Vaccination in the Prevention of Infectious Diseases at the Individual and Community Levels 
2.7.2. Evolution of Vaccines:  Types of Vaccines Currently Available 
2.7.3. Mechanisms of Action of Vaccines and Their Impact on the Immune System 
2.7.4. Efficacy and Safety of Vaccines in the Prevention of Infectious Diseases 
2.7.5. Importance of Vaccination in Risk Groups and in the Prevention of Epidemics 
2.7.6. Logistics and Vaccination Programs at the International Level 
2.7.7. Economic and Social Impact of Vaccination in the Prevention of Infectious Diseases 
2.7.8. Research and Analysis of Barriers and Challenges in the Implementation of Vaccination Programs 
2.7.9. Strategies and Measures to Promote Vaccination and to Raise Public Awareness of its Importance 
2.7.10 Evaluation and Critical Analysis of the Scientific Literature Related to Vaccines and their Usefulness in the Prevention of Infectious Diseases 

2.8. Emerging Diseases Epidemic Outbreaks 

2.8.1. Factors Favoring Emerging Diseases 
2.8.2. New Agents and Diseases 
2.8.3. International Health Regulations (IHR) 
2.8.4. Epidemic Outbreaks. Study, Control and Measures: Chemoprophylaxis, Immunoglobulins and Vaccines  

2.9. Viral Hepatitis, HIV infection, AIDS, Sexually Transmitted Infections (STIs) and Tuberculosis 

2.9.1. Hepatitis A: Etiology, Epidemiology and Preventive Measures 
2.9.2. Hepatitis B: Etiology, Epidemiology and Preventive Measures 
2.9.3. Other Viral Hepatitis: Etiology, Epidemiology and Preventive Measures 
2.9.4. HIV: Etiology, Epidemiology and Preventive Measures 
2.9.5. Sexually Transmitted Infections (STIs): Etiology, Epidemiology, and Preventive Measures 
2.9.6. Tuberculosis: Etiology, Epidemiology and Preventive Measures 

2.10. Meningococcal Disease (MD) and Zoonosis: Epidemiology Prevention and Control 

2.10.1. Epidemiology of Meningococcal Disease 
2.10.2. Prevention and Control of Meningococcal Disease 
2.10.3. Epidemiology of Zoonoses 
2.10.4. Prevention and Control of Zoonoses

Module 3. Clinical Epidemiology 

3.1. Design and Quality Assessment of Intervention Studies in Epidemiology 

3.1.1. Intervention Studies, Types and Key Design Elements 
3.1.2. Ethical Aspects of Intervention Research 
3.1.3. Design of Specific Intervention Studies 
3.1.4. Tools for Assessing the Quality of Intervention Studies 
3.1.5. Critical Appraisal of Intervention Studies 
3.1.6. Importance of Design and Quality Assessment 

3.2. Pragmatic vs. Explanatory Randomized Clinical Trials 

3.2.1. Differentiation Between Pragmatic and Explanatory Clinical Trials 
3.2.2. Ethical Implications of Each Approach 
3.2.3. Critical Evaluation of the Methodology and Design of Each Type of Trial 
3.2.4. Application of Knowledge to Clinical Practice and Research 
3.2.5. Promotion of Critical Thinking and Analytical Skills 
3.2.6. Design and Conduct of Clinical Studies 

3.3. Design of Diagnostic Test Studies 

3.3.1. Selection of the Study Population and Definition of Inclusion and Exclusion Criteria 
3.3.2. Determination of the Study Design and Selection of the Reference Methodology 
3.3.3. Calculation of Diagnostic Accuracy and Analysis of Results 

3.4. Evaluation of the Quality of a Diagnostic Test Study 

3.4.1. Study Validity Analysis 
3.4.2. Evaluation of the Accuracy of the Diagnostic Test 
3.4.3. Analysis of the Clinical Utility of the Diagnostic Test 

3.5. Design and Quality Assessment of Prognostic Factor Studies 

3.5.1. Selection and Definition of Prognostic Factors 
3.5.2. Study Design and Selection of the Study Population 
3.5.3. Evaluation of the Quality of the Study and the Prognostic Model 

3.6. Evidence-based Clinical Recommendations: GRADE 1 

3.6.1. Systematic Review of the Scientific Literature Identification of Clinical Recommendations 
3.6.2. Quality of Evidence and Strength of Recommendations 
3.6.3. Clinical Recommendations Applicable to Clinical Practice 
3.6.4. Development of Clinical Protocol or Clinical Guideline Based on the Identified Recommendations 
3.6.5. Implementation and Follow-up of the Clinical Protocol or Guideline in Patient Care Evidence and Focus on Improving Clinical Outcomes 
3.6.6. Periodic Evaluation, through Monitoring of Clinical Outcome Indicators and Feedback from the Health Professionals Involved 

3.7. Evidence-based Clinical Recommendations: GRADE 2 

3.7.1. Analysis and Synthesis of the Available Evidence in the Scientific Literature for the Development of Recommendations 
3.7.2. Identification and Evaluation of the Quality of the Relevant Studies that Support the Clinical Recommendations 
3.7.3. Application of the Principles of the GRADE Methodology to Establish the Strength and Certainty of Clinical Recommendations 
3.7.4. Developing Clinical practice Guidelines that Incorporate Evidence-based Recommendations and that are Useful for Clinical Decision Making 
3.7.5. Periodic Updating and Revision of Clinical Recommendations Based on the Available Scientific Evidence 

3.8. Evaluation of the Quality of Care 

3.8.1. Quality Criteria and Standards from the Point of View of Safety 
3.8.2. Evaluation of the Effectiveness of the Results obtained through the Actions Evaluated of the Actions Evaluated and their Components 
3.8.3. Measurement of Patient Outcomes and Experiences, Patient-Reported Outcome  Measures (PROM) and Patient-Reported Experience Measures (PREM) 
3.8.4. Indicators for Assessing the Degree of Involvement, Participation and Satisfaction of Healthcare Professionals 

3.9. Incorporation of Patients' Values and Preferences: Shared Decisions 

3.9.1. Effective Communication and Understanding of Values and Preferences 
3.9.2. Education and Counseling on Treatment Options 
3.9.3. Facilitation of Shared Decision Making 

3.10. Patient Safety 

3.10.1. Identification and Recording of Adverse Events 
3.10.2. Analysis of Errors and Underlying Causes 
3.10.3. Implementation of Corrective Actions and Prevention Measures

The teaching materials of this program, elaborated by these specialists, have contents that are completely applicable to your professional experiences"